Duffy Sean P. 4

What Happened
Sean P. Duffy, CEO of Omada Health, sold a total of 4,063 shares in open-market transactions on March 9, 2026 for aggregate proceeds of about $58,276. The sales consist of 3,863 shares at a weighted average price of $14.32 (reported value $55,299) and 200 shares at a weighted average price of $14.88 (reported value $2,977). These transactions are reported as sales (S) and were executed pursuant to a pre-established 10b5-1 trading plan.

Key Details

• Transaction date: March 9, 2026; Form 4 filed March 11, 2026 (filed within the 2-business-day reporting window).
• Prices and execution: 3,863 shares at $14.32 (weighted avg; execution prices ranged $13.81–$14.76), and 200 shares at $14.88 (weighted avg; execution prices ranged $14.86–$14.91). Reporting person will provide detailed per-trade counts/prices upon request (footnotes).
• Total proceeds: approx. $58,276.
• Plan: Transactions made under a 10b5-1 trading plan adopted August 15, 2025.
• Ownership after transaction: Not specified in the provided filing.
• Other note: Certain shares are held in family trusts for the benefit of family members; Mr. Duffy disclaims beneficial ownership of those trust-held shares except to the extent of any pecuniary interest.

Context
10b5-1 plans allow insiders to sell shares according to a pre-set schedule or criteria and are commonly used to avoid timing-based insider trading concerns. Sales executed under such plans are often routine and do not, by themselves, indicate a change in insider sentiment about the company.